• About
    • Company Overview
    • Management
    • Board of Directors
    • History
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Current Studies
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • Emavusertib
      (CA-4948)
    • CI-8993
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • Financial Statements
    • Stock Performance
      • Interactive Chart
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact
  • About
    • Company Overview
    • Management
    • Board of Directors
    • History
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Current Studies
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • Emavusertib
      (CA-4948)
    • CI-8993
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • Financial Statements
    • Stock Performance
      • Interactive Chart
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact

Curis CA-4948 NHL ASH Presentation 2020

© Curis, Inc. 2023 - All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • About
    • Company Overview
    • Management
    • Board of Directors
    • History
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Current Studies
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • Emavusertib
      (CA-4948)
    • CI-8993
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Investors
    • Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • Financial Statements
    • Stock Performance
      • Interactive Chart
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact